MedTrace Logo

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

NCT00253682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2014-03-18

No results posted yet for this study

Summary

This study will determine the impact of highly active antiretroviral therapy (HAART) on the developing cardiovascular system, the evolution of HAART-associated cardiovascular changes over time, and the association between cardiovascular measurements with HAART exposure.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Baylor College of Medicine

    collaborator OTHER

  • University of Illinois at Chicago

    collaborator OTHER

  • Clinical Trials & Surveys Corp (C-TASC)

    collaborator INDUSTRY

  • Columbia University

    collaborator OTHER

  • Boston Medical Center

    collaborator OTHER

  • University of Miami

    lead OTHER

Principal Investigators

  • Steven E. Lipshultz, MD · University of Miami

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00253682 on ClinicalTrials.gov